Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUITS: Varenicline and Nicotine Patch for Smoking Cessation
NCT03176784Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 2017
- Primary completion
- Jul 2020
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of varenicline + nicotine patch and nicotine patch in tobacco dependence, sponsored by University of Wisconsin–Madison. Started Nov 2017; status: completed.
02
Drugs
varenicline + nicotine patchnicotine patch
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT03176784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03176784.